Welcome to Business Insider‘s daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday.
Today in healthcare news: What Apple’s new products tell us about its healthcare ambitions, Pfizer’s execs are feeling confident on vaccine data by the end of October, and an inside look at a men’s health startup that’s become a key testing player.
Plus: We just got some data showing that one of the antibody drugs Eli Lilly’s developing with AbCellera might be able to help patients with COVID-19. In the group that took the medication, hospitalizations occurred in 1.7% of patients, compared to 6% of those who received a placebo. More on the results from Lilly here.
We just got new details on exactly how Pfizer could have definitive coronavirus vaccine data by Halloween
How a little-known men’s health startup became a key coronavirus testing partner for 61 colleges, SpaceX, and the NBA
More stories we’re reading:
Be sure to subscribe to this newsletter here! See you tomorrow.
Get the latest Pfizer stock price here.